Assyro AI

FDA Orange Book · active-ingredient family

Citric acid; magnesium oxide; sodium picosulfate

Citric acid; magnesium oxide; sodium picosulfate is approved as 2 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:CLENPIQ · NDA 209589

2

Brand (NDA)

1

Generics (ANDA)

7

Listed patents

0

Exclusivity periods

Brand (NDA) products · for solution, solution

ProductApplicantApplicationTEApproved
CLENPIQRLDFERRING PHARMS INCNDA 209589Nov 28, 2017
PREPOPIKRLDFERRING PHARMS INCNDA 202535Jul 16, 2012

Generic (ANDA) products (1)

ProductApplicantApplicationTEApproved
SODIUM PICOSULFATE, MAGNESIUM OXIDE AND ANHYDROUS CITRIC ACIDHETERO LABS LTD VANDA 212789Jul 18, 2022

Listed patents (7)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8450338Oct 10, 2028in 2 yr 4 mo
Product
8481083Oct 10, 2028in 2 yr 4 mo
Product
11191753Jun 23, 2034in 8 yr 2 mo
U-3261
12576072Jun 23, 2034in 8 yr 2 mo
ProductU-3261
10624879Jun 23, 2034in 8 yr 2 mo
Product
9827231Jun 26, 2034in 8 yr 2 mo
ProductU-2162
12458634Jan 27, 2038in 11 yr 9 mo
Product

Citric acid; magnesium oxide; sodium picosulfate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.